Keyphrases
Agonism
100%
Agonist Drugs
11%
Behavioral Causes
11%
Behavioral Measures
22%
Binding Potential
11%
Brain Regions
11%
Cigarette
22%
Cigarette Smoking
22%
Daily Smokers
11%
Dopamine Receptor
11%
Dopamine Release
100%
Dopamine System
11%
First-time-in-human
11%
Human Laboratory
11%
Human Studies
11%
Mechanistic Implication
11%
Mesolimbic
11%
Midbrain
11%
Nicotine
100%
Nicotine Craving
11%
Nicotine Use
11%
Nicotine Withdrawal
22%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Nicotinic Receptors
22%
Non-specific Binding
11%
Occupancy
33%
Partial Agonist
22%
Placebo
22%
Placebo Effect
11%
Placebo Groups
11%
Placebo-controlled Study
11%
Positron Emission Tomography
11%
Putamen
11%
Quit Rate
11%
Raclopride
33%
Receptor Binding
11%
Receptor Blockade
11%
Significant Relationship
11%
Smokers
11%
Smoking Cessation
11%
Smoking Cessation Intervention
11%
Smoking Quit Attempt
11%
Therapeutic Implications
11%
Twice Daily
11%
Varenicline
100%
Ventral Striatum
33%
Neuroscience
Agonist
11%
Dopamine Receptor
11%
Dopamine Release
100%
Fluorine-18
33%
Midbrain
11%
Nicotinic Acetylcholine Receptor
100%
Nicotinic Receptor
22%
Placebo
55%
Positron Emission Tomography
11%
Putamen
11%
Raclopride
33%
Receptor Binding
11%
Receptor Partial Agonist
11%
Thalamus
22%
Varenicline
100%
Ventral Striatum
33%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Potential
11%
Carbon 11
22%
Cigarette Smoking
22%
Dopamine Receptor
11%
Fluorine 18
33%
Human Study
11%
Nicotinic Receptor
100%
Partial Agonist
22%
Placebo
44%
Placebo-Controlled Study
11%
Raclopride
33%
Varenicline
100%